Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21

Shoulda posted this here, rather than on yesterday's SII thread:

As for yesterday's large volumes, I wouldn't be surprised if a fair bit was trading churn; there are a lot who buy on the good news, as well as those who sell. Some of those traders would buy and sell their own grandmothers. And for every seller, there is a buyer. Undoubtedly there is also trading that doesn't pass the smell test.

But I have not noticed yet on this thread (at the time of writing my initial post this morning), much comment about the content of the Quarterly, which I have read with considerable interest, and am pleased. David has made the point previously, that he makes here: "The Company continues to develop a portfolio approach to the market to ensure that there are multiple future revenue streams that include the high silicon anode, Anteo X and the new separator project." No need to repeat the "highlights"; none is a surprise, although some stand out as clearly moving ahead - e.g. EV1 and prototyping ("moves to evaluate" - hmm?), and EV2 ("scoping a development proposal"). And very glad to see the European appointment well under way - obviously selected candidate - a VP? A very north American title - an eye to the US market? Or a north American native? No, surely a European.

And yesterday's announcement about the SII contract? Well, I'm not surprised, but it has taken a while. Captainblood's comment is noteworthy, about the care shown in the terms of engagement. I can imagine there has been a fair bit of thrashing around about those; I can imagine that a draft contract emanating from a large organisation would express many conditions in its favour, and we have to pull them back from that. I expect the same from the EVs etc. They need to come to recognise that they need the technology, and it takes a while for that to sink in to their management. So I am expecting there is right now much too-ing and fro-ing between AnteoTech and its prospects. Meanwhile, the SII contract sends a strong signal to the Life Sciences market, and will certainly lead to further business with SII. Those contract conditions also serve as a marker, a template for how we will do business.

And agreed about Trinseo news - much better to tell us when an initiative is going nowhere; tell us so we know, and aren't left to guess the worst!

So, I am pleased, and am resigned to the fact that I will just have to live longer, to enjoy the fruits of my investment - and to see the positive results spilling out into the world.

Good wishes to all of us who sail in the wake of the good ship AnteoTech!